Difference between revisions of "Part:BBa K590034"

(Citations)
 
(24 intermediate revisions by 3 users not shown)
Line 2: Line 2:
 
<partinfo>BBa_K590034 short</partinfo>
 
<partinfo>BBa_K590034 short</partinfo>
  
This part encodes FabH2. [http://2011.igem.org/Team:Washington 2011 University of Washington iGEM Team] has produced  even chain length  alkanes using this part and the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick].  In addition, expression of this part and the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick] should theoretically produce branched chain alkanes, but we have not been able to demonstrate this effect, possibly due to the absence of the appropriate substrates in ''E. coli''
+
This part encodes FabH2. The [http://2011.igem.org/Team:Washington 2011 University of Washington iGEM Team] has produced  even chain length  alkanes using this part and the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick].  In addition, expression of this part and the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick] should theoretically produce branched chain alkanes, but we have not been able to demonstrate this effect, possibly due to the absence of the appropriate substrates in ''E. coli''
  
 
===Usage and Biology===
 
===Usage and Biology===
  
FabH2 is a FabH homolog from''Bacillus subtilis''. The FabH family of proteins initiates fatty acid elongation by converting an Acyl-CoA into an Acyl-ACP, with is extended by 2 carbon units to form longer chain length fatty acids. Normally, FabH proteins use a simple 2-carbon acetyl-CoA to start fatty acid biosynthesis, resulting in even chain length, linear fatty acids. However, FabH2 can also use Isobutyryl-CoA and Isovaleryl-CoA, (products from Valine, Leucine, and Isoleucine degradation), resulting in 2-methyl branched fatty acid production[1]. In addition, FabH2  has been hypothesized to start fatty acid elongation with a straight 3-carbon unit(propionyl-CoA), yielding odd chain length fatty acids, which could be converted into even chain length alkanes by the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick]. Expression of FabH2 on the same high copy number constitutive plasmid as the PetroBrick( as in Part [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 BBa_K590030]) results in slow cell growth, and low alkane yield( under 10 mg/L vs. approximately 170 mg/L in the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick]).
+
FabH2 is a FabH homolog from''Bacillus subtilis''. The FabH family of proteins initiates fatty acid elongation by converting an Acyl-CoA into an Acyl-ACP, with is extended by 2 carbon units to form longer chain length fatty acids. Normally, FabH proteins use a simple 2-carbon acetyl-CoA to start fatty acid biosynthesis, resulting in even chain length, linear fatty acids. However, FabH2 can also use Isobutyryl-CoA and Isovaleryl-CoA, (products from Valine, Leucine, and Isoleucine degradation), resulting in 2-methyl branched fatty acid production[1]. In addition, FabH2  has been hypothesized to start fatty acid elongation with a straight 3-carbon unit (propionyl-CoA), yielding odd chain length fatty acids, which could be converted into even chain length alkanes by the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick]. Expression of FabH2 on the same high copy number constitutive plasmid as the PetroBrick( as in Part [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 BBa_K590030]) results in slow cell growth, and low alkane yield( under 10 mg/L vs. approximately 170 mg/L in the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 Petrobrick]).
 
[[Image:Washington_growthcurve.png|center|450px|thumb|Growth curve showing that cells overexpressing FabH2 are growth deficient. [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590026 ADC] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590027 AAR] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 DrR] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 FabH2]
 
[[Image:Washington_growthcurve.png|center|450px|thumb|Growth curve showing that cells overexpressing FabH2 are growth deficient. [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590026 ADC] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590027 AAR] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 DrR] [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590030 FabH2]
 
]]
 
]]
Line 28: Line 28:
 
[[Image:Washington_2011_C14spectrum.png|left|800px|thumb|GCMS trace confirming C14 alkane produced only upon FabBrick induction. Black trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] alone. Red trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] + uninduced FabBrick. Green trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] + induced FabBrick.]]
 
[[Image:Washington_2011_C14spectrum.png|left|800px|thumb|GCMS trace confirming C14 alkane produced only upon FabBrick induction. Black trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] alone. Red trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] + uninduced FabBrick. Green trace from the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590025 PetroBrick] + induced FabBrick.]]
  
 +
<br clear="all">
 +
==FabH Information Contribution by team William_and_Mary 2020==
 +
===Intro===
  
 +
The FabH gene initiates the Fatty acid synthase II (FAS II) cycle. FAS enzymes can produce short chain fatty acids, long chain fatty acids, and complex fatty acids depending on the substrate availability and enzymes involved. FabH is also referred to as β-ketoacyl-ACP synthase III (KAS III). In general terms, the first step of Fatty acid synthesis involves KAS III acting as a condensation enzyme by “forming a carbon-carbon bond between acetyl-CoA and malonyl-ACP”. Subsequent reactions are carried out by enzymes called KAS I and KAS II to form fatty acids (Nofiani-Mahmoud, 2019).
  
 +
===Usage and Biology===
  
 +
In E. coli, the eFabH enzyme active site has a “catalytic triad” which is an arrangement of 3 amino acids-Cys112, His244 and Asn274. Its function first involves the transfer of the acetyl-CoA to cys112 on the KAS III protein to form an acyl-KAS III intermediate via a process called trans-thioesterification. Then, decarboxylation of  Malonyl-CoA forms an enolate anion that performs a nucleophilic attack on the acyl-KAS III carbonyl carbon. This forms the acetoacetyl-ACP product. While E. coli has a very high specificity for acetyl-CoA and is unable to use branched chain substrates, many bacteria are able to use different types of starting substrates to form fatty acids (Nofiani-Mahmoud, 2019).
 +
Most bacteria, including E. coli, have only one FabH gene. However some, like B. subtilis have two. B. subtilis has 2 orfs that correspond with the FabH gene in E. coli, bFabH1 and bFabH2 . The purpose of the presence of two FabH genes has not yet been elucidated.
 +
While some bacteria can initiate the FAS cycle using straight and branched substrates and are not restricted to just straight chain unsaturated fatty acids, eFabH like eFabH is. eFabH is incapable of using branched chain substrates as an initial substrate and is highly specific towards the simple 2-carbon Acetyl-CoA.
  
 +
Therefore, it is thought that the composition of fatty acids produced by broadly specific enzymes, like bFabH2, is determined largely by the initial substrate, and not by the specificity of the enzyme. For example, if the initial substrate is branched, then a high amount of branched fatty acids will be produced (Choi, 2000).  Acetyl-CoA, propionyl-CoA, and Butyryl-CoA are substrates that generally lead to the production of short chain fatty acids. Isopropyl-CoA, isobutyryl-CoA and methylbutyryl-CoA are substrates that lead to the production of branched chain fatty acids (Nofiani-Mahmoud, 2019).
  
 +
===Synthetic Biology applications===
 +
<p>
 +
Research showed that deletion of the FabH gene in E. coli heterologously expressing pfa genes from M. marina had three times the docosahexaenoic acid (a PUFA) production than wild type E. coli. Compared to the control strain which produced 2.8 +/- 0.4 mg DHA per liter of culture, the FabH mutant produced 11.2 +/- 1.9 mg DHA per liter of culture. This happened because the foreign PUFA synthase did not have to compete with the natural fatty acid synthesis pathway because FabH was disbaled . Additionally, the FabH mutant also has a decreased C16:0 production, 16.7% compared to 36.5% in the control strain. It also had an increased long chain fatty acid production like C18:1n7 production which went from 23.5% in the control strain to 45.2% in the mutant strain. The Folch method was used to isolate the fatty acids from the sample and gas chromatography was used to quantify each fatty acid. The mutant grew slower than the control and had a higher doubling time, 7.2 hours compared to 5.2 hours of the control. All cultures were grown at 15°C (Robles, 2018).
 +
</p>
  
 +
https://static.igem.org/mediawiki/parts/7/7d/T--William_and_Mary--FabH_Characterization_Chart.png
  
 +
(^Robles, 2018) The graph highlights the three fold increase in DHA (C22:6n3) production in the FabH mutant compared to the wild type strain. The graph is showing %DHA produced relative to total fatty acids.
 +
Overexpressing FabH reduced fatty acid synthesis and increased Malonyl-CoA levels in the cell. The cellular Malonyl-CoA concentration increased by 49%and Went from 2.45 ± 0.02 nmol/mgDCW in the control to 3.78 ± 0.03 nmol/mgDCW in the FabH overexpressing strain. The total fatty acid production decreased in the FabH overexpressing strain. It went from 27.25 ± 0.08mg/L/OD in the control to 22.53 ± 0.02mg/L/OD in the FabH overexpressing strain (Cao, 2016).
 +
Additionally, because the FabH gene of E. coli is unable to use and produce branched chain fatty acids, heterologous expression of FabH genes from organisms that can use branched chain fatty acid substrates in E. coli led to the production of branched chain 17-carbon fatty acids. This emphasizes the importance of the substrate specificity of FabH in determining the characteristics of the end product (Choi, 2000).
 +
===References===
 +
Choi KH, Heath RJ, Rock CO. beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. J Bacteriol. 2000;182(2):365-370. doi:10.1128/jb.182.2.365-370.2000
  
 +
Giner-Robles, Laura et al. “fabH deletion increases DHA production in Escherichia coli expressing Pfa genes.” Microbial cell factories vol. 17,1 88. 8 Jun. 2018, doi:10.1186/s12934-018-0928-5
  
 +
Nofiani R, Philmus B, Nindita Y, Mahmud T. 3-Ketoacyl-ACP synthase (KAS) III homologues and their roles in natural product biosynthesis. Medchemcomm. 2019;10(9):1517-1530. Published 2019 Apr 29. doi:10.1039/c9md00162j
  
 +
Weijia Cao, Weichao Ma et al. “Improved pinocembrin production in Escherichia coli by engineering fatty acid synthesis”. Journal of Industrial Microbiology & Biotechnology. Volume 43, Pages 557–566(2016).
  
  
 +
<br clear="all">
  
 
+
==Functional Parameters: Austin_UTexas==
 
+
<html>
 
+
<body>
 
+
<partinfo>BBa_K590034 parameters</partinfo>
 
+
<h3><center>Burden Imposed by this Part:</center></h3>
 
+
<figure>
 
+
<div class = "center">
 
+
<center><img src = "https://static.igem.org/mediawiki/parts/f/fa/T--Austin_Utexas--no_burden_icon.png" style = "width:160px;height:120px"></center>
 
+
</div>
 
+
<figcaption><center><b>Burden Value: 1.5 ± 5.8% </b></center></figcaption>
 
+
</figure>
 
+
<p> Burden is the percent reduction in the growth rate of <i>E. coli</i> cells transformed with a plasmid containing this BioBrick (± values are 95% confidence limits). This BioBrick did not exhibit a burden that was significantly greater than zero (i.e., it appears to have little to no impact on growth). Therefore, users can depend on this part to remain stable for many bacterial cell divisions and in large culture volumes. Refer to any one of the
 
+
<a href="https://parts.igem.org/Part:BBa_K3174002">BBa_K3174002</a> - <a href="https://parts.igem.org/Part:BBa_K3174007">BBa_K3174007</a> pages for more information on the methods, an explanation of the sources of burden,  and other conclusions from a large-scale measurement project conducted by the <a href="http://2019.igem.org/Team:Austin_UTexas">2019 Austin_UTexas team</a>.</p>
 
+
<p>This functional parameter was added by the <a href="https://2020.igem.org/Team:Austin_UTexas/Contribution">2020 Austin_UTexas team.</a></p>
 
+
</body>
 
+
</html>
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
  
 
==Reference==
 
==Reference==
 
1.Beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. Choi KH, Heath RJ, Rock CO. J Bacteriol. 2000 Jan;182(2):365-70.
 
1.Beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. Choi KH, Heath RJ, Rock CO. J Bacteriol. 2000 Jan;182(2):365-70.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K590034 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K590034 SequenceAndFeatures</partinfo>

Latest revision as of 22:06, 18 December 2020

FabH2

This part encodes FabH2. The [http://2011.igem.org/Team:Washington 2011 University of Washington iGEM Team] has produced even chain length alkanes using this part and the Petrobrick. In addition, expression of this part and the Petrobrick should theoretically produce branched chain alkanes, but we have not been able to demonstrate this effect, possibly due to the absence of the appropriate substrates in E. coli

Usage and Biology

FabH2 is a FabH homolog fromBacillus subtilis. The FabH family of proteins initiates fatty acid elongation by converting an Acyl-CoA into an Acyl-ACP, with is extended by 2 carbon units to form longer chain length fatty acids. Normally, FabH proteins use a simple 2-carbon acetyl-CoA to start fatty acid biosynthesis, resulting in even chain length, linear fatty acids. However, FabH2 can also use Isobutyryl-CoA and Isovaleryl-CoA, (products from Valine, Leucine, and Isoleucine degradation), resulting in 2-methyl branched fatty acid production[1]. In addition, FabH2 has been hypothesized to start fatty acid elongation with a straight 3-carbon unit (propionyl-CoA), yielding odd chain length fatty acids, which could be converted into even chain length alkanes by the Petrobrick. Expression of FabH2 on the same high copy number constitutive plasmid as the PetroBrick( as in Part BBa_K590030) results in slow cell growth, and low alkane yield( under 10 mg/L vs. approximately 170 mg/L in the Petrobrick).

Growth curve showing that cells overexpressing FabH2 are growth deficient. ADC AAR DrR FabH2

By moving FabH2 into a low copy number inducible vector(As in The FabBrick) ,we were able to get C14 and C16 alkane production, completing the alkane spectrum from C13 to C17. This is the first time that even chain length alkanes have been recombinately produced.This construct was co-transformed with the Petrobrick in XL1-Blue E. coli. When FabH2 was induced by adding 5uM IPTG, a peak corresponding to the C16 were observed. This was confirmed from the MS spectrum, which had an overall fingerprint consistent with alkane, and a parent ion at a mass of 226, confirming the identity as C16 alkane. In addition, a peak corresponding to the C14 alkane was observed, completing the alkane spectrum from C13 to C17. This is the first time that even chain length alkanes have been recombinately produced. This part requires further optimization in order to further increase total alkane yield( currently at approximately 40 mg/L vs 170 mg/L for the Petrobrick), and to increase the amount of C14/C16 alkane yield, as current yield is only approximately 4 mg/L.

GCMS trace confirming C16 alkane produced only upon FabBrick induction. Black trace from the PetroBrick alone. Red trace from the PetroBrick + uninduced FabBrick. Green trace from the PetroBrick + induced FabBrick.








GCMS trace confirming C14 alkane produced only upon FabBrick induction. Black trace from the PetroBrick alone. Red trace from the PetroBrick + uninduced FabBrick. Green trace from the PetroBrick + induced FabBrick.


FabH Information Contribution by team William_and_Mary 2020

Intro

The FabH gene initiates the Fatty acid synthase II (FAS II) cycle. FAS enzymes can produce short chain fatty acids, long chain fatty acids, and complex fatty acids depending on the substrate availability and enzymes involved. FabH is also referred to as β-ketoacyl-ACP synthase III (KAS III). In general terms, the first step of Fatty acid synthesis involves KAS III acting as a condensation enzyme by “forming a carbon-carbon bond between acetyl-CoA and malonyl-ACP”. Subsequent reactions are carried out by enzymes called KAS I and KAS II to form fatty acids (Nofiani-Mahmoud, 2019).

Usage and Biology

In E. coli, the eFabH enzyme active site has a “catalytic triad” which is an arrangement of 3 amino acids-Cys112, His244 and Asn274. Its function first involves the transfer of the acetyl-CoA to cys112 on the KAS III protein to form an acyl-KAS III intermediate via a process called trans-thioesterification. Then, decarboxylation of Malonyl-CoA forms an enolate anion that performs a nucleophilic attack on the acyl-KAS III carbonyl carbon. This forms the acetoacetyl-ACP product. While E. coli has a very high specificity for acetyl-CoA and is unable to use branched chain substrates, many bacteria are able to use different types of starting substrates to form fatty acids (Nofiani-Mahmoud, 2019). Most bacteria, including E. coli, have only one FabH gene. However some, like B. subtilis have two. B. subtilis has 2 orfs that correspond with the FabH gene in E. coli, bFabH1 and bFabH2 . The purpose of the presence of two FabH genes has not yet been elucidated. While some bacteria can initiate the FAS cycle using straight and branched substrates and are not restricted to just straight chain unsaturated fatty acids, eFabH like eFabH is. eFabH is incapable of using branched chain substrates as an initial substrate and is highly specific towards the simple 2-carbon Acetyl-CoA.

Therefore, it is thought that the composition of fatty acids produced by broadly specific enzymes, like bFabH2, is determined largely by the initial substrate, and not by the specificity of the enzyme. For example, if the initial substrate is branched, then a high amount of branched fatty acids will be produced (Choi, 2000). Acetyl-CoA, propionyl-CoA, and Butyryl-CoA are substrates that generally lead to the production of short chain fatty acids. Isopropyl-CoA, isobutyryl-CoA and methylbutyryl-CoA are substrates that lead to the production of branched chain fatty acids (Nofiani-Mahmoud, 2019).

Synthetic Biology applications

Research showed that deletion of the FabH gene in E. coli heterologously expressing pfa genes from M. marina had three times the docosahexaenoic acid (a PUFA) production than wild type E. coli. Compared to the control strain which produced 2.8 +/- 0.4 mg DHA per liter of culture, the FabH mutant produced 11.2 +/- 1.9 mg DHA per liter of culture. This happened because the foreign PUFA synthase did not have to compete with the natural fatty acid synthesis pathway because FabH was disbaled . Additionally, the FabH mutant also has a decreased C16:0 production, 16.7% compared to 36.5% in the control strain. It also had an increased long chain fatty acid production like C18:1n7 production which went from 23.5% in the control strain to 45.2% in the mutant strain. The Folch method was used to isolate the fatty acids from the sample and gas chromatography was used to quantify each fatty acid. The mutant grew slower than the control and had a higher doubling time, 7.2 hours compared to 5.2 hours of the control. All cultures were grown at 15°C (Robles, 2018).

T--William_and_Mary--FabH_Characterization_Chart.png

(^Robles, 2018) The graph highlights the three fold increase in DHA (C22:6n3) production in the FabH mutant compared to the wild type strain. The graph is showing %DHA produced relative to total fatty acids. Overexpressing FabH reduced fatty acid synthesis and increased Malonyl-CoA levels in the cell. The cellular Malonyl-CoA concentration increased by 49%and Went from 2.45 ± 0.02 nmol/mgDCW in the control to 3.78 ± 0.03 nmol/mgDCW in the FabH overexpressing strain. The total fatty acid production decreased in the FabH overexpressing strain. It went from 27.25 ± 0.08mg/L/OD in the control to 22.53 ± 0.02mg/L/OD in the FabH overexpressing strain (Cao, 2016). Additionally, because the FabH gene of E. coli is unable to use and produce branched chain fatty acids, heterologous expression of FabH genes from organisms that can use branched chain fatty acid substrates in E. coli led to the production of branched chain 17-carbon fatty acids. This emphasizes the importance of the substrate specificity of FabH in determining the characteristics of the end product (Choi, 2000).

References

Choi KH, Heath RJ, Rock CO. beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. J Bacteriol. 2000;182(2):365-370. doi:10.1128/jb.182.2.365-370.2000

Giner-Robles, Laura et al. “fabH deletion increases DHA production in Escherichia coli expressing Pfa genes.” Microbial cell factories vol. 17,1 88. 8 Jun. 2018, doi:10.1186/s12934-018-0928-5

Nofiani R, Philmus B, Nindita Y, Mahmud T. 3-Ketoacyl-ACP synthase (KAS) III homologues and their roles in natural product biosynthesis. Medchemcomm. 2019;10(9):1517-1530. Published 2019 Apr 29. doi:10.1039/c9md00162j

Weijia Cao, Weichao Ma et al. “Improved pinocembrin production in Escherichia coli by engineering fatty acid synthesis”. Journal of Industrial Microbiology & Biotechnology. Volume 43, Pages 557–566(2016).



Functional Parameters: Austin_UTexas

BBa_K590034 parameters

Burden Imposed by this Part:

Burden Value: 1.5 ± 5.8%

Burden is the percent reduction in the growth rate of E. coli cells transformed with a plasmid containing this BioBrick (± values are 95% confidence limits). This BioBrick did not exhibit a burden that was significantly greater than zero (i.e., it appears to have little to no impact on growth). Therefore, users can depend on this part to remain stable for many bacterial cell divisions and in large culture volumes. Refer to any one of the BBa_K3174002 - BBa_K3174007 pages for more information on the methods, an explanation of the sources of burden, and other conclusions from a large-scale measurement project conducted by the 2019 Austin_UTexas team.

This functional parameter was added by the 2020 Austin_UTexas team.

Reference

1.Beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis. Choi KH, Heath RJ, Rock CO. J Bacteriol. 2000 Jan;182(2):365-70. Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 310
    Illegal AgeI site found at 949
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 355